StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Adds to Strong Gains; Sets Sights on $90
November 20, 2015 1:10 PM
Short seller target Valeant Pharma (NYSE: VRX) is seeing notably strength ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Short Sales
Trader Talk
Next Articles
Left for Dead Valeant Pharma (VRX) Is Up 30% In a Week
November 23, 2015 10:43 AM
Valeant Pharmaceuticals (VRX) Reiterated Top Pick at Mizuho Securities; PT to $111
November 20, 2015 6:36 AM
Citi Credit Research Sees Opportunity in Valeant (VRX), Initiates With Overweight Rating (MNK) (ENDP)
November 19, 2015 9:28 AM
